NantHealth to Present at the Cowen and Company 37th Annual Health Care Conference On March 7
March 1, 2017
CULVER CITY, Calif.--(BUSINESS WIRE)--
NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based,
personalized healthcare company, today announced that the company will
present at the Cowen and Company 37th Annual Health Care Conference on
Tuesday, March 7, 2017, at 9:20 a.m. ET at the Boston Marriott Copley
Place hotel.
An audio-only webcast of the presentation will be available at www.NantHealth.com.
Listeners are encouraged to visit the web site at least 10 minutes prior
to the start of the presentation to register, download and install any
necessary software. The presentation will be archived and accessible on
the web site for at least 90 days.
About NantHealth, Inc.
NantHealth, Inc., a member of the NantWorks ecosystem of companies, is a
next-generation, evidence-based, personalized healthcare company
enabling improved patient outcomes and more effective treatment
decisions for critical illnesses. NantHealth’s unique systems-based
approach to personalized healthcare applies novel diagnostics tailored
to the specific molecular profiles of patient tissues and integrates
this molecular data in a clinical setting with large-scale, real-time
biometric signal and phenotypic data to track patient outcomes and
deliver precision medicine. For nearly a decade, NantHealth has
developed an adaptive learning system, CLINICS, which includes its
unique software, middleware and hardware systems infrastructure that
collects, indexes, analyzes and interprets billions of molecular,
clinical, operational and financial data points derived from novel and
traditional sources, continuously improves decision-making and further
optimizes our clinical pathways and decision algorithms over time. For
more information please visit www.nanthealth.com and
follow Dr. Soon-Shiong on Twitter @DrPatSoonShiong.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170301006606/en/
for NantHealth, Inc.
Investor Contact:
Robert Jaffe,
424-288-4098
rjaffe@rjaffeco.com
Source: NantHealth, Inc.